Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s DiseaseRoland W. Bürli, Celia Dominguez, Maria Beconi et al.|Journal of Medicinal Chemistry|2013Cited by 149
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitorChristopher A. Luckhurst, Celia Dominguez, Omar Aziz et al.|Bioorganic & Medicinal Chemistry Letters|2018Cited by 46
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s DiseaseLongbin Liu, Ignacio Muñoz-Sanjuán, Karine Malagu et al.|Journal of Medicinal Chemistry|2023Cited by 7